New insulin analogues and their impact on diabetes care.
The rising incidence of diabetes means that it is no longer viable for patients to be treated solely within the secondary care setting and primary health-care professionals, including community nurses working within community-based diabetes clinics, are likely to continue to take on greater responsibility for the assessment and management of patients with diabetes. This article discusses recent advances in insulin therapy--namely the advent of the new insulin analogues--and examines their likely impact on community nurses in terms of improved time management and quality of care for patients with diabetes on patients in terms of improved quality of care.
Hill
Jill
J
Eastern Birmingham PCT, Birmingham, UK. jill.hill@easternbirminghampct.nhs.uk
D003152:Community Health Nursing / Q000379:methods; D003422:Critical Care / Q000379:methods; D003920:Diabetes Mellitus / Q000188:drug therapy* / Q000451:nursing / Q000523:psychology; D004334:Drug Administration Schedule; D006801:Humans; D007328:Insulin / Q000031:analogs & derivatives* / Q000032:analysis* / Q000494:pharmacology / Q000627:therapeutic use*; D000069036:Insulin Glargine; D049528:Insulin, Long-Acting; D017060:Patient Satisfaction; D016896:Treatment Outcome; D016526:Workload
D007328:Insulin; D049528:Insulin, Long-Acting; D000069036:Insulin Glargine